Skip to main content
Log in

Use of dimethicone to reduce the fall in gastric potential difference induced by bile salts

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The gastric potential difference (PD) was measured in ten healthy volunteers after sodium taurocholate intake. This bile salt was given after treatment with dimethicone or placebo in a cross-over design study.

With dimethicone the fall in PD was lower (16.1 vs. 24.8 mV,) and shorter (32.5 vs. 51.0 min) than with the placebo.

Our result suggests that the silicone can prevent the formation of the gastric lesions induced by bile salts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Papazian A, Capron SP (1984) Reflux duodéno-gastrique. In: JJ Bernier (ed) Gastroenterologie. Flammarion, Paris vol 1: 345–348

    Google Scholar 

  2. Black RB, Naylor F, Stenhouse NS (1977) Gastric mucosal damage by taurine and glycine conjugates of chenodesoxycholic acid. Am J Dig Dis 22: 1106–1108

    Google Scholar 

  3. Harmon JW, Lewis CD, Gadacz T (1981) Bile salt composition and concentration as determinants of canine gastric mucosal injury. Surgery 89: 348–354

    Google Scholar 

  4. Geall MG, Phillips SF, Summerskill WHJ (1970) Profile of gastric potential difference in man. Effects of aspirin, alcohol, bile and endogenous acid. Gastroenterology 58: 437–443

    Google Scholar 

  5. Murray HS, Strottmann MP, Cooke AR (1974) Effect of several drugs on gastric potential difference in man. Br Med J 267: 19–21

    Google Scholar 

  6. Laule H, Lucker PW, Altmayer P, Eldon MA (1981) Gastric potential difference as a model in clinical pharmacology. Eur J Clin Pharmacol 22: 147–152

    Google Scholar 

  7. Isal JP, Caulin C, Simoneau G, Dahan R (1984) La mesure de la différence de potentiel gastrique induite par l'aspirine. Therapie 39: 7–11

    Google Scholar 

  8. von Caspary WF, Kausch H (1977) Antazida und Magenschleimhaut. Fortschr Med 95: 1931–1934

    Google Scholar 

  9. Baskin WN, Ivey KJ, Krause WJ, Jeffrey GE, Gemmell RT (1976) Aspirin-induced ultrastructural changes in human gastric mucosa. Correlation with potential difference. Ann Int Med 85: 299–303

    Google Scholar 

  10. Florent C, Flourie B, Pfeiffer A, Bernier JJ (1985) Mesure de la différence de potentiel trans-épitheliale gastrique. Effets des agents agressifs et des pansements gastriques. Gastroenterol Clin Biol 9 [Suppl]: 58–64

    Google Scholar 

  11. Ritchie WP (1977) Bile acids, the “barrier” and reflux-related clinical disorders of the gastric mucosa. Surgery 82: 192–200

    Google Scholar 

  12. Caulin D, Simoneau G (1986) Mesure de l'effet cytoprotecteur du Gel de Polysilane Midy. La Pratique Med 28: 39–40

    Google Scholar 

  13. Dahan R, Schatz B, Isal JP, Caulin C (1984) Effet de la smectite sur les modifications de difference de potentiel gastrique induites par l'aspirine chez l'homme. Gastroenterol. Clin Biol 8: 878–879

    Google Scholar 

  14. Chaudhury TK, Robert A (1980) Prevention by mild irritants of gastric necrosis produced in rats by sodium taurocholate. Dig Dis Sci 25: 830–836

    Google Scholar 

  15. Robert A, Nezamis JE, Lancaster C (1984) Mild irritants prevent gastric necrosis through “adaptative cytoprotection” mediated by prostaglandins. Am J Physiol 245: 113–121

    Google Scholar 

  16. Konturek SJ, Radecki T, Prastuski I (1987) Gastro-cytoprotection by colloidal bismuth subcitrate and sucralfate. Role of endogenous prostaglandins. Gut 28: 201–205

    Google Scholar 

  17. Quadros E, Johnson JV, Wilson DE (1986) antacids stimulate prostaglandin release from gastric mucosa. Gastroenterology 90: 1595

    Google Scholar 

  18. Bergmann JF, Caulin C, Simoneau G, Dorf G, Segrestaa JM (1988) Persistent gastric protective effect of antacid evaluated by measurement of transmucosal gastric potential difference. Clin Pharm Therap 44: 546–549

    Google Scholar 

  19. Hollander D, Tarnawski A, Gergely H, Zipser RD (1984) Sucralfate protection of the gastric mucosa against ethanol-induced injury. Scand J Gastroenterol 19: 97–102

    Google Scholar 

  20. Cohen MM (1981) Prevention of aspirin-induced fall in gastric potential difference with prostaglandins. Lancet 1: 785

    Google Scholar 

  21. Graham DY, Agrawal NM, Roth SM (1988) Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 2: 1277–1280

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bergmann, J.F., Simoneau, G., Chantelair, G. et al. Use of dimethicone to reduce the fall in gastric potential difference induced by bile salts. Eur J Clin Pharmacol 36, 379–381 (1989). https://doi.org/10.1007/BF00558299

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558299

Key words

Navigation